Multimorbidity or polypharmacy: two sides of the same coin?

Affiliations

Editorial

Carol Sinnott et al. J Comorb. 2015.

. 2015 Apr 24:5:29-31.

doi: 10.15256/joc.2015.5.51. eCollection 2015.

No abstract available

Keywords: Comorbidity; chronic disease; information sharing; patient care management; polypharmacy; primary health care.

Conflict of interest statement

None declared.

1. Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. Br Med J. 2015;350:h1059. View Item. - DOI - PubMed
1. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012:5–CD008165. View Item. - DOI - PubMed
1. Guthrie B, Makubate B. The rising tide of polypharmacy and potentially serious drug interactions 1995–2010: repeated cross sectional analysis of dispensed prescribing in one region. Prim Health Care Res Devel. 2012;13(Suppl 1):45.
1. Almirall J, Fortin M. The coexistence of terms to describe the presence of multiple concurrent diseases. J Comorbidity. 2013;3:4–9. View Item. - DOI - PMC - PubMed
1. Tinetti ME, Bogardus ST, Jr., Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870–4. View Item. - DOI - PubMed